The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells
Andrew Freywald, Mónica V. Estrada, Tanya Freywald, Frederick S. Vizeacoumar et al.
Citations
1 citations
Journal
Cancer Cell International
Topics
Mitochondrial Function and Pathology
Field-Weighted Citation Impact (FWCI)
0.81
article
The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells
Andrew Freywald, Mónica V. Estrada, Tanya Freywald, Frederick S. Vizeacoumar, Scot C. Leary, Behzad M. Toosi, Amr El Zawily, Franco J. Vizeacoumar, Tetiana Katrii
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer Cell InternationalVol. 25(1)
Institutions
University of Iowa (US), University of Saskatchewan (CA), Saskatchewan Cancer Agency (CA)
Funders
Cancer Research Society, Canadian Institutes of Health Research